Updated Jul 16, 2026 · Last SEC filing 2026-07-01
PALVELLA THERAPEUTICS, INC. (PVLA) has filed 11 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-01. 7 Form 8-K material event filings were reported by PVLA in the last 90 days. 3 Form 144 notices of proposed sale were filed for PVLA stock. InsiderAlpha tracks every PVLA SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SEC CIK | 0001583648 |
|---|
| Form 4 filings (90d) | 11 |
|---|---|
| Form 8-K filings (90d) | 7 |
| Form 144 notices (90d) | 3 |
| Latest Form 4 filing | 2026-07-01 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Goin Kathleen | Chief Operating Officer | S — Open-market sale | 2.4K | $110.26 | $264K | SEC | |
| Goin Kathleen | Chief Operating Officer | S — Open-market sale | 1.9K | $111.31 | $210K | SEC | |
| Goin Kathleen | Chief Operating Officer | S — Open-market sale | 25 | $112.23 | $3K | SEC | |
| Goin Kathleen | Chief Operating Officer | M — Option exercise | 2.1K | $9.08 | $20K | SEC | |
| Goin Kathleen | Chief Operating Officer | M — Option exercise | 2.2K | $7.14 | $15K | SEC | |
| Korenberg Matthew E | CFO, Treasurer | M — Option exercise | 1.0K | $13.60 | $14K | SEC | |
| Goin Kathleen | Chief Operating Officer | S — Open-market sale | 48 | $111.89 | $5K | SEC | |
| Goin Kathleen | Chief Operating Officer | M — Option exercise | 2.2K | $7.14 | $15K | SEC | |
| Goin Kathleen | Chief Operating Officer | S — Open-market sale | 3.4K | $110.35 | $371K | SEC | |
| Goin Kathleen | Chief Operating Officer | S — Open-market sale | 891 | $111.30 | $99K | SEC | |
| Goin Kathleen | Chief Operating Officer | M — Option exercise | 2.1K | $9.08 | $20K | SEC | |
| Goin Kathleen | Chief Operating Officer | M — Option exercise | 2.2K | $7.14 | $15K | SEC | |
| Goin Kathleen | Chief Operating Officer | M — Option exercise | 2.1K | $9.08 | $20K | SEC | |
| Goin Kathleen | Chief Operating Officer | S — Open-market sale | 100 | $130.33 | $13K | SEC | |
| Goin Kathleen | Chief Operating Officer | S — Open-market sale | 639 | $129.17 | $83K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for PALVELLA THERAPEUTICS, INC. (PVLA). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Goin Kathleen | 23 | $1.60M |
| Korenberg Matthew E | 2 | $14K |
| Pauls Matthew | 1 | — |
| HERON ELAINE J | 1 | — |
| KIRITSY CHRISTOPHER P | 1 | — |
Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in PVLA insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live PVLA dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.